A unique opportunity to acquire the assets of GoodLux Technology – a pioneer in wearables for digital health. The assets being sold include the SunSprite device business and issued & pending US and foreign patents.

This is a unique opportunity to acquire the assets of the pioneer in wearable light tracking devices and applications for digital health and wellness. GoodLux is a Boston-based startup founded in 2012 that developed the SunSprite Wearable Light Tracker (http://www.sunsprite.com). The SunSprite provides direct feedback to the user as well as communicates measurement data to a smartphone app (iOS and Android) for analysis and tracking over time. Bright light exposure has a direct relationship to circadian rhythm that is important in mood, sleep and performance. The SunSprite has been used in trials for treatment of depression, sleep issues and to optimize athletic performance.

The assets of the company are being packaged into two lots.
Lot A – Patent Assets: One patent family including the issued US patent: 9,163,983 B2 with an open continuation, a pending EP application and a second pending application (US, CN)
Lot B – SunSprite Device Business: device inventory, SunSprite.com website, mobile applications and trademark.

More details about the assets, reserve pricing and sale process can be found at: https://mjkpartners.com/sales/goodluxassets/. If you have any questions about the assets being sold, the sale process or would like to be kept informed, please contact Myron Kassaraba at 617-871-9558 or email: goodluxassetsale(at)mjkpartners(dot)com.

From: http://www.prweb.com/releases/2016/GoodLuxAssetSale/prweb13349165.htm